Browse the complete record of transactions filed by 김종호, Chief Executive Officer. Insider active across 1 company, notably 화일약품. Cumulatively, 17,943 reports have been logged. History available since 4 March 2026. The latest transaction was disclosed on 4 March 2026 (Purchase). Regulator: DART (FSS). All data is free.
Kim Jong-ho is the Managing Director at Hwa-il Pharmaceutical, where he oversees the company's operations and strategy. With significant experience in the industry, he plays a key role in driving growth and innovation initiatives. Kim Jong-ho is recognized for his ability to lead teams and build strong relationships with business partners.